戻る
ZYUS Life Sciences Corp (ZLSCF)価格
ZLSCF 株価推移チャート
ZLSCF 財務
ZYUS Life Sciences Corp
$0.05
-91.05%
$-0.5
終値： Feb 13, 16:00:00 GMT-5
$0.05
0%
$0
アフターマーケット：Feb 13, 20:00:00 GMT-5
主要データ
前終値
$0.56
始値
$0.0401
当日レンジ
$0.0401 - $0.0501
52週レンジ
$0.0501 - $0.66
取引高
--
平均取引高
468
1株当たり利益(TTM)
-0.34
配当利回り
--
時価総額
$3.9M
ZYUS LIFE SCIENCES CORPとは何ですか？
ZYUS Life Sciences Corp. is a Canadian-based life sciences company. The company is headquartered in Saskatoon, Saskatchewan. The company went IPO on 2000-10-18. Its lead research program is focused on developing a purified cannabinoid formulation to treat chronic pain due to cancer, musculoskeletal injuries and arthritis. Its lead/first drug product candidate in this program, Trichomylin softgel capsules, is a fixed dose combination of cannabinoids formulated for the treatment of chronic pain in adults. This formulation offers oral administration of highly purified cannabinoids in a controlled dosage. In parallel with the research conducted respecting Trichomylin softgel capsules, it has also identified and commenced research on a second drug candidate. This drug candidate is a cannabinoid-based therapeutic composition for pain management. Both pre-clinical and non-clinical studies have been conducted on this formulation and patent applications have been filed.